Allozyne Inc / Dove Medical Press Ltd. / Dove Press / GE / Biogen Idec / Merck Serono / Lundstrom K. Review / Hepatitis C Intervention Therapy Group / Multiple Sclerosis Collaborative Research Group / Ambrx Inc / BaroFold Inc / /
Country
Switzerland / France / United States / Brazil / / /
Event
FDA Phase / / /
IndustryTerm
treatment of hepatitis C / treatment of multiple sclerosis / injection site / present magnetic resonance imaging / polymer-based sustained release technology / pharmaceuticals / treatment of MS / pharmaceutical proteins / hepatitis C treatment / /
MedicalCondition
MS Disease / influenza-like illness / tumor necrosis factor-alpha / HCV genotype 1 / rheumatoid arthritis / mouse tumor / prevalent neurological disease / chronic hepatitis C. Hepatology / hepatitis C / melanoma / multiple sclerosis / MS / decreases tumor necrosis / autoimmune diseases / cancers / Cancer / disease / Greek chronic hepatitis C / Chronic / Crohn’s disease / initial high disease / Statkevich P. Treating cancer / hepatic injury / liver fibrosis / pain / tumor necrosis / diseases / adenosine deaminase deficiency / infection / chronic progressive MS / chronic doses / depression / Oschmann P. Autoimmune hepatitis / chronic hepatitis C / /
MedicalTreatment
chemotherapy / immunosuppression / /
Organization
Chronic administration / IM administration / Reinhard Reuss Department of Neurology / /
Person
Ann Neurol / Nuron Biotech / Reinhard Reuss / Mire Zloh / Xue Za Zhi / Berthold W. Polyethylene / / /
Microsoft Word - 10_Apr_2013_29948_Reuss_100413.doc